3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Completed
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Classical hematology
39
Breast
10
Other hematologic neoplasm
9
Plasma cell
4
Thoracic
3
Gastrointestinal
3
Other
2
Lymphoid
2
Gynecologic
1
Genitourinary
1
Conditions
Obesity
219
Neoplasms
82
Mucositis
66
Sexual Dysfunction, Physiological
65
Breast Neoplasms
64
Polycystic Ovary Syndrome
56
Overweight
55
Dyspnea
32
Motor Activity
30
Constipation
30
Head and Neck Neoplasms
28
Prostatic Neoplasms
25
Weight Loss
24
Multiple Endocrine Neoplasia Type 1
19
Colorectal Neoplasms
18
Pain
16
Diabetes Mellitus
16
Stomatitis
15
Lung Neoplasms
15
Opioid-Induced Constipation
14
Depression
14
Cardiovascular Diseases
14
Insulin Resistance
13
Endometrial Neoplasms
13
Sexuality
11
Sexual Dysfunctions, Psychological
11
Diabetes Mellitus, Type 2
11
Fatigue
10
Anxiety Disorders
10
Stomach Neoplasms
8
Interventions
Interleukin 1 Receptor Antagonist Protein
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Completed
×
Febrile Neutropenia
×
Other
×
Clear all
NCT03233776
2024-11-18
AFFECT-1
Radboud University Medical Center
Phase 2
Completed
9 enrolled
NCT04099901
2024-11-18
AFFECT-2
Radboud University Medical Center
Phase 2
Completed
88 enrolled